Clinical Trial Update: Ticagrelor and Anti-inflammatory Effects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ticagrelor for anti-inflammatory effects in chronic kidney disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: Kyunghee University Medical Center | Conditions: Chronic Kidney Disease | Phase 3 | Status: UNKNOWN